NAPROXEN SODIUM TABLETS
Država: Kanada
Jezik: engleski
Izvor: Health Canada
Svojstava lijeka
(SPC)
31-01-2012
Neki dokumenti za ovaj proizvod trenutno nisu dostupni, možete poslati zahtjev u našu korisničku službu i mi ćemo vas obavijestiti čim ih budemo mogli dobiti.
Pošalji zahtjev.
Pošalji zahtjev.
Aktivni sastojci:
NAPROXEN SODIUM
Dostupno od:
VITA HEALTH PRODUCTS INC
ATC koda:
M01AE02
INN (International ime):
NAPROXEN
Doziranje:
220MG
Farmaceutski oblik:
TABLET
Sastav:
NAPROXEN SODIUM 220MG
Administracija rute:
ORAL
Jedinice u paketu:
24/100/250/500
Tip recepta:
OTC
Područje terapije:
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
Proizvod sažetak:
Active ingredient group (AIG) number: 0113934003; AHFS:
Status autorizacije:
APPROVED
Datum autorizacije:
2012-01-30
Svojstava lijeka
_Page 1 of 35_
PRODUCT MONOGRAPH
NAPROXEN SODIUM TABLETS
NAPROXEN SODIUM CAPLETS
NAPROXEN SODIUM TABLETS USP, 220 MG
Non-steroidal anti-inflammatory drug
Analgesic, Antipyretic
Vita Health Products Inc.
150 Beghin Avenue, Winnipeg
Manitoba, Canada R2J 3W2
Date of Preparation:
January 26, 2012
Control No.: 134246
_Page 2 of 35_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION.............................................................................3
SUMMARY PRODUCT INFORMATION
.............................................................................................
3
INDICATIONS AND CLINICAL USE
...................................................................................................
3
CONTRAINDICATIONS
........................................................................................................................
4
WARNINGS AND PRECAUTIONS
.......................................................................................................
4
ADVERSE REACTIONS
.........................................................................................................................
6
DRUG INTERACTIONS
.........................................................................................................................
9
DOSAGE AND ADMINISTRATION
...................................................................................................11
OVERDOSAGE
.....................................................................................................................................12
ACTION AND CLINICAL PHARMACOLOGY
..................................................................................12
STORAGE AND STABILITY
...............................................................................................................13
SPECIAL HANDLING INSTRUCTIONS
............................................................................................13
DOSAGE FORMS, COMPOSITION AND PACKAGING
..................................................................14
PART II:
Pročitajte cijeli dokument
